Related Experiment Video
Updated: Aug 5, 2026
09:31
Individualized Stem-positioning in Calcar-guided Short-stem Total Hip Arthroplasty
Published on: February 27, 2018
[APPLICATION OF PREPARATION OF COCARNIT FOR PATIENTS AFTER ENDOPROSTHESIS OF HIP AND KNEE JOINTS]
Likars'Ka Sprava
|April 20, 2016
Summary
Cocarnit improves patient well-being after major joint replacement surgery. This supplement reduced somatic complaints and showed good tolerability with no significant adverse effects observed in clinical research.
Area of Science:
- Orthopedic Surgery
- Pharmacology
- Clinical Medicine
Context:
- Post-operative recovery following major joint replacement.
- Patient-reported outcomes and somatic complaints.
- Clinical efficacy and tolerability of pharmacological interventions.
Purpose:
- To evaluate the clinical efficiency and safety of Cocarnit in patients undergoing major joint replacement.
- To assess the impact of Cocarnit on patient-reported somatic state and laboratory parameters.
- To determine the influence of Cocarnit on metabolic markers post-surgery.
Summary:
- Clinical research investigated Cocarnit's efficacy in patients post-major joint replacement.
- Patients receiving Cocarnit reported fewer somatic complaints and generally good tolerability.
- Key laboratory and clinical blood indices remained stable, indicating good safety and bearability.
Impact:
- Cocarnit application led to a decline in cholesterol, glycoproteins, and malonic dialdehyde levels.
- It also normalized alanine aminotransferase activity, suggesting a positive influence on key metabolic processes.
- Findings support Cocarnit's role in improving post-operative recovery and metabolic balance in joint replacement patients.
